The Trial That Disappeared
How $NWBO’s DCVax-L May Have Cracked Colorectal Cancer and Why No One Will Talk About It
📖 Editor’s Note:
This is a long-form investigative analysis (~15-minute read). It explores the scientific, regulatory, and commercial dimensions of a vanished Phase II immunotherapy trial with far-reaching implications. For anyone following DCVax-L, checkpoint inhibitors, or MSS colorectal cancer, this is essential reading.📝 Special thanks to @d_stock07734 for organizational collaboration, archival diligence, and editorial guidance.....
🎖️ Full credit to @maveric92283613 for identifying the trial, framing its implications, and flagging the erasure as early as 2019.
🔗 Original 2019 post by Maverick
investorshub.advfn.com/boards/read_ms…